EFFETS CYTOTOXIQUES D'ANTIGLAUCOMATEUX EN CULTURES DE CELLULES CONJONCTIVALES HUMAINESTAKAHASHI N.1981; NIHON GANKA GAKKAI ZASSHI; ISSN 0029-0203; JPN; DA. 1981; VOL. 85; NO 8; PP. 204-209; ABS. ENG; BIBL. 16 REF.Article

EXPERIENCE DE L'APPLICATION CLINIQUE DU TIMOLOL EN SOLUTION OPHTALMIQUENAKANO N.1980; NIPPON GANKA KIYO; ISSN 0015-5667; JPN; DA. 1980; VOL. 31; NO 7; PP. 1189-1194; ABS. ENG; BIBL. 16 REF.Article

ADDITION OF PINDOLOL TO ROUTINE MEDICAL THERAPY: A CLINICAL TRIALSMITH RJH; BLAMIRES T; NAGASUBRAMANIAN S et al.1982; BR. J. OPHTHALMOL.; ISSN 0007-1161; GBR; DA. 1982; VOL. 66; NO 2; PP. 102-108; BIBL. 3 REF.Article

TRADITIONAL ANTIGLAUCOMA THERAPY: A CLINICAL SURVEY OF SIDE EFFECTSSTAFFORD WR.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 2; PP. 265-274; BIBL. 8 REF.Article

STUDIES OF ACTION MECHANISM OF ANTIGLAUCOMA DRUGS WITH A NEWLY DEVELOPED CAT MODELCHIOU GCY; LIU HK; TRZECIAKOWSKI J et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 25-26; PP. 2445-2451; BIBL. 33 REF.Article

LES ANTIGLAUCOMATEUX: DES MEDICAMENTS EFFICACES DONT LE MECANISME D'ACTION EST MAL CONNURENAUD B.1980; LYON PHARM.; ISSN 0024-7804; FRA; DA. 1980; VOL. 31; NO 5; PP. 301-302Article

EFFET DE LA SOLUTION OPHTALMIQUE DE TIMOLOL SUR LA TENSION OCULAIRE DANS LE GLAUCOMEMASUNAGA J; TOMODA T; NAITO S et al.1980; NIPPON GANKA KIYO; ISSN 0015-5667; JPN; DA. 1980; VOL. 31; NO 7; PP. 1195-1200; ABS. ENG; BIBL. 8 REF.Article

EFFECTS OF N-DEMETHYLATED CARBACHOL ON IRIS AND CILIARY MUSCLESTRZECIAKOWSKI J; CHIOU GCY.1980; J. PHARM. SCI.; USA; DA. 1980; VOL. 69; NO 3; PP. 332-334; BIBL. 13 REF.Article

PHARMACOLOGICAL EFFECTS OF TOPICAL TIMOLOL IN THE RABBIT EYEBARTELS SP; ROTH HO; JUMBLATT MM et al.1980; INVEST. OPHTHALMOL. VISUAL SCI.; USA; DA. 1980; VOL. 19; NO 10; PP. 1189-1197; BIBL. 22 REF.Article

SERUM CHOLINESTERASE, SERUM LIPASE, AND SERUM AMYLASE LEVELS DURING LONG-TERM ECHOTHIOPHATE IODIDE THERAPYFRIBERG TR; THOMAS JV; DRESSEL TD et al.1981; AM. J. OPHTHALMOL.; ISSN 0002-9394; USA; DA. 1981; VOL. 91; NO 4; PP. 530-533; BIBL. 9 REF.Article

COMPARAISON DES EFFETS SECONDAIRES SUR LA FONCTION VISUELLE DE DEUX COLLYRES HYPOTONISANTS: INCIDENCE AERONAUTIQUE LORS DE L'EXPERTISE OPHTALMOLOGIQUE DU PERSONNEL NAVIGANTMANENT PJ; MAILLE M; MAUCLAIR C et al.1980; MED. AERONAUT. SPAT., MED. SUBAQU. HYPERBARE; ISSN 0399-6417; FRA; DA. 1980; VOL. 19; NO 74; PP. 125-128; 3 P.Article

VOIES D'ACCES ET INTERET THERAPEUTIQUE POTENTIEL DES CANNABINOIDES ET ANALOGUES = ROUTE OF ADMINISTRATION AND THERAPEUTIC POSSIBILITIES OF SOME CANNABINOIDS AND ANALOGSLE COGUIC YVAN.1981; ; FRA; DA. 1981; 72 P.; 30 CM; BIBL. 22 REF.; TH.: PHARM./NANTES/1981/4Thesis

Spanish multicenter tafluprost tolerability studyMILLA, Elena; STIRBU, Oana; REY, Amanda et al.British journal of ophthalmology. 2012, Vol 96, Num 6, pp 826-831, issn 0007-1161, 6 p.Article

Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyesDUZMAN, E; ROSEN, N; LAZAR, M et al.British journal of ophthalmology. 1983, Vol 67, Num 10, pp 668-673, issn 0007-1161Article

Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissueITO, Tadashi; OHGURO, Hiroshi; MAMIYA, Kazuhisa et al.Investigative ophthalmology & visual science. 2006, Vol 47, Num 3, pp 823-830, issn 0146-0404, 8 p.Article

The pharmacology of antiglaucoma drugsSUGRUE, M. F.Pharmacology & therapeutics (Oxford). 1989, Vol 43, Num 1, pp 91-138, issn 0163-7258Article

EFFET TENSIONNEL DE L'ASSOCIATION TIMOLOL-ADRENALINE. ETUDE PRELIMINAIREARRATA M; MASSIN M.1980; J. FR. OPHTALMOL.; FRA; DA. 1980; VOL. 3; NO 5; PP. 359-362; ABS. ENG; BIBL. 9 REF.Article

Adoption of New Antiglaucoma Drugs in Finland : Impact of Changes in CopaymentMARTIKAINEN, Jaana E; HÄKKINEN, Unto; ENLUND, Hannes et al.Clinical therapeutics. 2007, Vol 29, Num 11, pp 2468-2476, issn 0149-2918, 9 p.Article

Bimatoprost: A novel antiglaucoma agentWOODWARD, D. F; PHELPS, R. L; KRAUSS, A. H-P et al.Cardiovascular drug reviews (Print). 2004, Vol 22, Num 2, pp 103-120, issn 0897-5957, 18 p.Article

Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedropsKOZOBOLIS, Vassilios P; DETORAKIS, Efstathios T; MASKALERIS, George et al.American journal of ophthalmology. 2005, Vol 139, Num 4, pp 742-743, issn 0002-9394, 2 p.Article

Update on the use of prostaglandin analogs in glaucoma therapyCAMRAS, Carl B; TORIS, Carol B; ALM, Albert et al.Survey of ophthalmology. 2002, Vol 47, issn 0039-6257, 239 p., SUP1Serial Issue

Effects of AGN 192024, a new Ocular Hypotensive agent, on aqueous dynamicsBRUBAKER, Richard F; SCHOFF, Erik O; NAU, Cherie B et al.American journal of ophthalmology. 2001, Vol 131, Num 1, pp 19-24, issn 0002-9394Article

Bétagan collyre (lévobunolol) = Betagan eye drop (levobunolol)La Revue Prescrire. 1995, Vol 15, Num 152, pp 414-415, issn 0247-7750Article

Differential pulse polarographic assay of timolol maleateALVAREZ-LUEJE; NUNEZ-VERGARA, L. J; SQUELLA, J. A et al.Farmaco (Il) : (1989). 1991, Vol 46, Num 4, pp 593-600, 8 p.Article

On cardiovascular effects of topical glaucoma therapy [2(2&3):99, 1983]. ReplyNOVACK, G. D; MCDONALD, T. O; DE SOUSA, B et al.Journal of toxicology. Cutaneous and ocular toxicology. 1984, Vol 3, Num 3, pp 243-250, issn 0731-3829Article